S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Stock market today: Asian shares mostly lower after Wall St has its worst week in 6 months
Writers Guild and Hollywood studios reach tentative deal to end strike. No deal yet for actors
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
AI is on the world's mind. Is the UN the place to figure out what to do about it?
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
Investing Legend Warns: NVIDIA is a "Delusion" (Ad)
Canadian autoworkers ratify new labor agreement with Ford
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
NASDAQ:MIRM

Mirum Pharmaceuticals (MIRM) Short Interest Ratio & Short Volume

$30.72
-1.20 (-3.76%)
(As of 09/22/2023 08:52 PM ET)
Compare
Today's Range
$30.69
$32.12
50-Day Range
$24.63
$32.85
52-Week Range
$17.32
$33.39
Volume
296,100 shs
Average Volume
507,866 shs
Market Capitalization
$1.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$53.33

Mirum Pharmaceuticals Short Interest Data

Current Short Volume
5,080,000 shares
Previous Short Volume
5,050,000 shares
Change Vs. Previous Month
+0.59%
Dollar Volume Sold Short
$134.26 million
Short Interest Ratio / Days to Cover
9.0
Last Record Date
August 31, 2023
Outstanding Shares
38,300,000 shares
Float Size
25,210,000 shares
Short Percent of Float
20.15%
Today's Trading Volume
296,100 shares
Average Trading Volume
507,866 shares
Today's Volume Vs. Average
58%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Mirum Pharmaceuticals ?

Sign up to receive the latest short interest report for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MIRM Short Interest Over Time

MIRM Days to Cover Over Time

MIRM Percentage of Float Shorted Over Time


Mirum Pharmaceuticals (NASDAQ:MIRM) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/20235,080,000 shares $134.26 million +0.6%20.2%9 $26.43
8/15/20235,050,000 shares $129.73 million +24.7%18.7%9.4 $25.69
7/31/20234,050,000 shares $104.33 million +35.0%14.9%7.5 $25.76
7/15/20233,000,000 shares $78.75 million -8.0%11.1%5.7 $26.25
6/30/20233,260,000 shares $84.34 million +10.1%12.1%5.3 $25.87
6/15/20232,960,000 shares $83.15 million +0.7%11.0%5.1 $28.09
5/31/20232,940,000 shares $77.12 million -7.3%11.8%5.6 $26.23
5/15/20233,170,000 shares $82.52 million +1.6%12.7%6.4 $26.03
4/30/20233,120,000 shares $83.77 million +4.4%13.0%6.6 $26.85
4/15/20232,990,000 shares $74.72 million +69.9%12.5%6.3 $24.99
3/31/20231,760,000 shares $42.28 million -10.2%7.2%4.5 $24.02
3/15/20231,960,000 shares $46.31 million +7.1%8.0%6.5 $23.63
2/28/20231,830,000 shares $43.02 million -2.7%7.7%5.7 $23.51
2/15/20231,880,000 shares $42.41 million +14.6%7.9%5.6 $22.56
1/31/20231,640,000 shares $38.51 million +42.6%7.1%4.5 $23.48
1/15/20231,150,000 shares $25.30 million +9.5%4.9%3.2 $22.00
12/30/20221,050,000 shares $20.48 million -13.2%4.5%2.8 $19.50
12/15/20221,210,000 shares $21.62 million -18.8%5.3%3.1 $17.87
11/30/20221,490,000 shares $27.79 million -11.8%6.6%3.7 $18.65
11/15/20221,690,000 shares $33.85 million -8.2%7.4%4.3 $20.03
10/31/20221,840,000 shares $41.49 million -10.2%8.2%4.4 $22.55
10/15/20222,050,000 shares $39.20 million -18.3%9.2%5 $19.12
9/30/20222,510,000 shares $52.74 million +6.4%11.2%6.6 $21.01
9/15/20222,360,000 shares $54.09 million +0.9%10.5%7.1 $22.92
8/31/20222,340,000 shares $58.45 million +8.3%11.4%7.9 $24.98
8/15/20222,160,000 shares $55.58 million +1.9%10.6%7.5 $25.73
7/31/20222,120,000 shares $53.21 million +0.5%11.5%8.1 $25.10
7/15/20222,110,000 shares $50.91 million +5.0%11.7%9.2 $24.13
6/30/20222,010,000 shares $39.11 million +21.8%11.1%8.8 $19.46
6/15/20221,650,000 shares $31.17 million +16.2%9.2%7.3 $18.89
5/31/20221,420,000 shares $33.21 million +67.9%7.9%7.4 $23.39
5/15/2022846,000 shares $20.30 million +13.7%4.7%4.7 $24.00
4/30/2022744,300 shares $17.70 million +14.0%4.1%4.3 $23.78
4/15/2022653,000 shares $17.96 million +19.8%3.6%3.6 $27.50
3/31/2022545,100 shares $12.00 million -27.2%3.2%3 $22.02
3/15/2022748,800 shares $16.21 million +55.7%4.4%4.3 $21.65
2/28/2022480,900 shares $11.40 million +2.7%2.9%2.9 $23.70
2/15/2022468,200 shares $10.28 million -18.1%2.8%2.8 $21.95
1/31/2022571,900 shares $10.89 million +20.3%3.5%3.5 $19.05
1/15/2022475,500 shares $8.91 million +5.2%2.8%3.5 $18.74













MIRM Short Interest - Frequently Asked Questions

What is Mirum Pharmaceuticals' current short interest?

Short interest is the volume of Mirum Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 5,080,000 shares of MIRM short. 20.15% of Mirum Pharmaceuticals' shares are currently sold short. Learn More on Mirum Pharmaceuticals' current short interest.

What is a good short interest ratio for Mirum Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIRM shares currently have a short interest ratio of 9.0. Learn More on Mirum Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Mirum Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mirum Pharmaceuticals: Citadel Advisors LLC, Wolverine Asset Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Mirum Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.15% of Mirum Pharmaceuticals' floating shares are currently sold short.

Is Mirum Pharmaceuticals' short interest increasing or decreasing?

Mirum Pharmaceuticals saw a increase in short interest in August. As of August 31st, there was short interest totaling 5,080,000 shares, an increase of 0.6% from the previous total of 5,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Mirum Pharmaceuticals' float size?

Mirum Pharmaceuticals currently has issued a total of 38,300,000 shares. Some of Mirum Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mirum Pharmaceuticals currently has a public float of 25,210,000 shares.

How does Mirum Pharmaceuticals' short interest compare to its competitors?

20.15% of Mirum Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Mirum Pharmaceuticals: Syndax Pharmaceuticals, Inc. (10.02%), Disc Medicine Opco Inc (2.19%), Revance Therapeutics, Inc. (16.27%), Day One Biopharmaceuticals, Inc. (20.35%), Sage Therapeutics, Inc. (18.03%), Aurinia Pharmaceuticals Inc. (9.73%), Geron Co. (6.36%), Kiniksa Pharmaceuticals, Ltd. (5.49%), Biohaven Ltd. (9.03%), MannKind Co. (14.58%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Mirum Pharmaceuticals stock?

Short selling MIRM is an investing strategy that aims to generate trading profit from Mirum Pharmaceuticals as its price is falling. MIRM shares are trading down $1.20 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mirum Pharmaceuticals?

A short squeeze for Mirum Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MIRM, which in turn drives the price of the stock up even further.

How often is Mirum Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIRM, twice per month. The most recent reporting period available is August, 31 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:MIRM) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -